US Corporate Distress Financial Stress SEC Filings — February 11, 2026

12-02-2026

SOLV Energy, Inc. filed a multi-item Form 8-K on 2026-02-12 reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), material modifications to rights of security holders (Item 3.03), departures or elections of directors/officers including compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws and/or change in fiscal year (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No quantitative transaction values, financial impacts, share counts, or performance metrics are disclosed. The filing covers both potentially strategic developments and governance/equity changes with unknown directional implications.

11-02-2026

AMERICAN REBEL HOLDINGS INC filed an 8-K on 2026-02-11 under Items 3.01 (Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing), 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing signals a core delisting event alongside equity sales and disclosures, with no quantitative financial metrics, transaction values, or performance comparisons disclosed. No positive or offsetting metrics are mentioned.

11-02-2026

Ernexa Therapeutics Inc. filed an 8-K on February 11, 2026 (AccNo: 0001493152-26-006227), reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details provided on the agreement, events, transaction value, financial impacts, or metrics. No positive, negative, or flat performance metrics are disclosed.

11-02-2026

Galecto, Inc. filed a Form 8-K on February 11, 2026, reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits, likely related to the agreement. No specific terms, transaction values, financial impacts, or quantitative metrics are provided in the filing summary.

11-02-2026

STRATA Skin Sciences, Inc. filed a Form 8-K on 2026-02-11 disclosing under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Item 8.01 reports Other Events. No quantitative financial metrics, transaction values, or period-over-period comparisons are disclosed.

11-02-2026

Evolution Petroleum Corp filed an 8-K on February 11, 2026, disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 reports financial statements and exhibits. No transaction details, financial metrics, dollar values, or impacts are disclosed.

• ·AccNo: 0001104659-26-013485
• ·File Size: 550 KB

11-02-2026

The company filed an 8-K on February 11, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, with financial statements and exhibits attached under Item 9.01. No specific details, dollar values, parties, terms, or financial impacts are disclosed in the provided filing summary. This is a multi-item mandatory disclosure of material events with no quantitative metrics or comparisons available.

11-02-2026

Horizon Technology Finance Corp filed an 8-K on February 11, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, parties, financial impacts, or quantitative metrics are provided in the filing summary. No positive or negative performance metrics, period-over-period changes, or guidance revisions are mentioned.

11-02-2026

Evergy, Inc. filed a Form 8-K on 2026-02-11 reporting entry into a material definitive agreement (Item 1.01), termination of a material definitive agreement (Item 1.02), and creation of a direct financial obligation or an obligation under an off-balance sheet arrangement (Item 2.03), with financial statements and exhibits attached (Item 9.01). No specific details, dollar values, parties, or impacts are disclosed. This multi-item filing signals changes in agreements and obligations, but lacks quantitative data for assessment.

11-02-2026

ZYNEX INC filed an 8-K on 2026-02-11 (AccNo: 0001104659-26-013411) disclosing a bankruptcy or receivership event under Item 1.03. No additional details on the type of proceedings, financial impacts, debts, assets, or restructuring plans are provided in the filing summary. This event represents a material adverse development with no counterbalancing positive metrics mentioned.

11-02-2026

Energy Vault Holdings, Inc. filed an 8-K on February 11, 2026, disclosing under Item 1.01 entry into a material definitive agreement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on the agreement, events, transaction values, financial impacts, or metrics are provided in the filing summary. No positive or negative metrics, comparisons, or directional indicators are mentioned.

11-02-2026

Apple iSports Group, Inc. filed an 8-K on February 11, 2026 (AccNo: 0001477932-26-000755), reporting under Item 1.02 the termination of a material definitive agreement. No details on the agreement's nature, parties, dollar value, strategic role, or financial implications were disclosed. This is a single-item mandatory disclosure with no other metrics or comparisons provided.

11-02-2026

CID Holdco, Inc. filed a Form 8-K on February 11, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, and under Item 3.01 notice of delisting or failure to satisfy a continued listing rule or standard, with Item 9.01 providing financial statements and exhibits. No quantitative details such as transaction values, financial impacts, dollar amounts, or specific terms are disclosed. This multi-item filing suggests potential financial distress without offsetting positive metrics disclosed.

11-02-2026

Cipher Mining Inc. filed an 8-K on February 11, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, with exhibits provided under Item 9.01. This multi-item filing signals a significant contractual event with potential financial implications, but no specific transaction details, values, or impacts are disclosed. No quantitative metrics, positive or negative changes, or performance comparisons are mentioned.

11-02-2026

National Bank Holdings Corp filed a Form 8-K on February 11, 2026, reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, along with Regulation FD disclosure in Item 7.01 and exhibits in Item 9.01. No quantitative details such as transaction values, financial terms, or impacts on revenue, earnings, balance sheet, or guidance are disclosed. This multi-item filing signals significant contractual and financing activity but provides no metrics for positive or negative assessment.

11-02-2026

Abpro Holdings, Inc. filed a Form 8-K on 2026-02-11 reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing, which is a material negative event signaling potential loss of exchange trading status. The filing is multi-item, also disclosing under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No quantitative financial metrics, transaction values, or other numerical data are disclosed.

11-02-2026

Interactive Strength, Inc. filed an 8-K on 2026-02-11 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), and Item 3.02 (Unregistered Sales of Equity Securities). This multi-item filing indicates a likely financing-related transaction involving a new agreement, financial obligation, and equity issuance, but no quantitative details, terms, or impacts are disclosed. No positive or negative metrics, comparisons, or guidance changes are provided.

11-02-2026

Teradata Corp filed an 8-K on February 11, 2026 (AccNo: 0001628280-26-007274), disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 provides for financial statements and exhibits. No specific transaction details, financial metrics, dollar values, or impacts are disclosed in the provided filing summary.

11-02-2026

Local Bounti Corporation/DE filed a Form 8-K on 2026-02-11 under Items 3.01, 7.01, and 9.01, disclosing a notice of delisting or failure to satisfy a continued listing rule or standard, along with Regulation FD disclosure and financial statements/exhibits. This event signals non-compliance with exchange listing requirements, potentially leading to transfer to over-the-counter trading. No quantitative financial metrics, positive developments, or period-over-period comparisons were disclosed.

• ·AccNo: 0001628280-26-007269
• ·Filing size: 194 KB
• ·Multi-item 8-K filing (Items 3.01, 7.01, 9.01)

11-02-2026

Phoenix Motor Inc. filed an 8-K on February 11, 2026 (AccNo: 0001493152-26-006203), reporting under Item 3.03 for material modifications to rights of security holders, Item 5.03 for amendments to articles of incorporation or bylaws or change in fiscal year, and Item 9.01 for financial statements and exhibits. This is a multi-item mandatory disclosure with no quantitative financial metrics, transaction values, or performance comparisons disclosed. Specific details on the nature, scope, or impact of the modifications or amendments are not provided.

11-02-2026

Gladstone Investment Corporation filed an 8-K on February 11, 2026, reporting under Item 1.01 its entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No specific details regarding the agreement's parties, terms, value, financial impacts, or any quantitative metrics are provided.

11-02-2026

Southern California Edison Co filed an 8-K on 2026-02-11 under Item 1.01 disclosing entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, terms, or financial impacts are disclosed.

11-02-2026

Millerknoll, Inc. filed an 8-K on February 11, 2026 (AccNo: 0000066382-26-000031), disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No specific transaction details, dollar values, financial metrics, positive or negative impacts, or period-over-period comparisons are disclosed.

11-02-2026

Independence Realty Trust, Inc. filed a multi-item Form 8-K on February 11, 2026, reporting entry into a material definitive agreement (Item 1.01) and termination of a material definitive agreement (Item 1.02), alongside results of operations and financial condition (Item 2.02) and creation of a direct financial obligation (Item 2.03). Regulation FD disclosure (Item 7.01) was also included with financial statements and exhibits (Item 9.01). No specific transaction details, financial metrics, dollar values, or performance comparisons are disclosed.

11-02-2026

Microchip Technology Inc filed a Form 8-K on February 11, 2026 (AccNo: 0001193125-26-046713), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific transaction details, dollar values, parties, impacts, or quantitative metrics disclosed in the provided information.

12-02-2026

Southwest Gas Holdings, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001193125-26-047540), reporting under Item 1.02 the termination of a material definitive agreement. No financial terms, parties involved, strategic rationale, or impacts are disclosed.

12-02-2026

Applied Materials Inc./DE filed a Form 8-K on February 12, 2026 (AccNo: 0001628280-26-007444, Size: 208 KB), reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the core event, disclosures, financial statements, or exhibits are provided. This is a multi-item filing with no quantitative metrics, positive or negative, disclosed.

12-02-2026

TransUnion filed a multi-item 8-K on February 12, 2026 (AccNo: 0001552033-26-000006), reporting entry into a material definitive agreement under Item 1.01, results of operations and financial condition under Item 2.02, and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, with Regulation FD disclosure under Item 7.01. Specific details on the agreement terms, transaction size, financial results, and obligation amounts are NOT_DISCLOSED. No quantitative metrics, period-over-period comparisons, or directional impacts (positive, negative, or flat) are provided in the filing summary.

12-02-2026

AquaBounty Technologies Inc. filed an 8-K on February 12, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction terms, financial metrics, positive or negative impacts, or quantitative data are disclosed. This is a multi-item mandatory filing with no period-over-period comparisons or guidance provided.

12-02-2026

Axos Financial, Inc. filed a Form 8-K on 2026-02-12 under Item 1.01 disclosing entry into a Material Definitive Agreement. Item 9.01 provides Financial Statements and Exhibits. No further details on the agreement, transaction size, financial impacts, or other metrics are disclosed.

12-02-2026

Onconetix, Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0001213900-26-015212, Size: 1 MB), reporting entry into a material definitive agreement under Item 1.01 and other events under Item 8.01. Item 9.01 includes financial statements and exhibits. No specific transaction details, financial metrics, positive or negative impacts, or quantitative data are disclosed.

12-02-2026

VerifyMe, Inc. filed a multi-item 8-K on February 12, 2026, disclosing entry into a new material definitive agreement (Item 1.01) while simultaneously terminating another material definitive agreement (Item 1.02), alongside changes involving departure or election of directors/officers and compensatory arrangements (Item 5.02), and Regulation FD disclosure (Item 7.01). No quantitative financial details, transaction values, or specific impacts are provided in the filing summary. Item 9.01 lists financial statements and exhibits, but contents are not detailed.

12-02-2026

Xerox Holdings Corp filed a Form 8-K on February 12, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction terms, financial impacts, or quantitative metrics are provided in the available filing summary.

12-02-2026

Tectonic Financial, Inc. filed an 8-K on February 12, 2026, reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03. The filing also includes Regulation FD disclosure under Item 7.01 and lists financial statements and exhibits under Item 9.01. No quantitative details, dollar values, strategic impacts, or performance metrics are disclosed.

12-02-2026

Totaligent, Inc. filed an 8-K on February 12, 2026, reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No details on the agreement's terms, parties, value, strategic importance, or financial impact were disclosed. This is a multi-item mandatory filing with no quantitative metrics or period-over-period comparisons provided.

12-02-2026

Contango ORE, Inc. filed an 8-K on February 12, 2026, disclosing entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction size, financial impacts, or events are provided in the available information. No quantitative metrics, positive or negative changes, or period-over-period comparisons are disclosed.

12-02-2026

Indaptus Therapeutics, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001493152-26-006330), reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with financial statements and exhibits under Item 9.01. No quantitative details such as transaction values, share counts, or financial impacts are disclosed. This is a multi-item filing focused on material contractual and equity events without specified positive or negative metrics.

12-02-2026

Aspire Biopharma Holdings, Inc. filed a multi-item Form 8-K on February 12, 2026, disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), departures or appointments of directors/officers or compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details, transaction values, financial impacts, or quantitative metrics are disclosed in the provided filing summary. No positive or negative metrics are mentioned.

12-02-2026

Fresh Del Monte Produce Inc filed an 8-K on 2026-02-12 disclosing entry into a material definitive agreement under Item 1.01. The filing also includes financial statements and exhibits under Item 9.01. No details on the agreement terms, parties, financial impact, or quantitative metrics are provided.

12-02-2026

FVCBankcorp, Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0001675644-26-000006, size: 25 MB), reporting multiple items including entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No quantitative metrics, transaction details, financial impacts, period-over-period comparisons, or specific terms are disclosed.

• ·Multi-item 8-K filing (5 items reported)
• ·File size: 25 MB (suggests detailed exhibits)

12-02-2026

CIM Real Estate Finance Trust, Inc. filed an 8-K on February 12, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No transaction details, dollar values, financial metrics, or impacts are disclosed.

12-02-2026

Jet.AI Inc. filed a multi-item 8-K on February 12, 2026, disclosing entry into a material definitive agreement under Item 1.01, which may have strategic implications, but also a notice of delisting or failure to satisfy a continued listing rule or standard under Item 3.01, signaling potential removal from exchange listing and liquidity risks. Item 8.01 reports other events and Item 9.01 includes financial statements and exhibits. No transaction values, financial impacts, or specific details on the agreement or delisting triggers are disclosed.

12-02-2026

Beam Therapeutics Inc. filed an 8-K on 2026-02-12 disclosing entry into a material definitive agreement under Item 1.01, accompanied by financial statements and exhibits under Item 9.01. No specific details on the agreement's terms, parties, value, or financial impacts are disclosed. No quantitative metrics, positive or negative changes, or performance comparisons are provided.

• ·AccNo: 0001193125-26-048684
• ·Filing size: 230 KB

12-02-2026

Solaris Energy Infrastructure, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001193125-26-048667), reporting under Item 1.01 entry into a Material Definitive Agreement. No details on the core event, transaction value, parties involved, financial impact, or strategic importance are disclosed. No quantitative metrics, period-over-period comparisons, or other data points such as revenue, earnings, guidance, or balance sheet effects are provided.

12-02-2026

agilon health, inc. filed a Form 8-K on February 12, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, parties, terms, or financial impacts are disclosed in the provided filing summary.

• ·Accession Number: 0001628280-26-007671
• ·Multi-item 8-K filing (Items 1.01, 2.03, 9.01)
• ·Sector: NOT_DISCLOSED

12-02-2026

CVR Energy Inc. filed an 8-K on February 12, 2026, disclosing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, with exhibits under Item 9.01. This multi-item filing signals a significant contractual commitment and new financial liability, but no details on terms, size, or impacts are provided. No quantitative metrics, positive or negative changes, or performance comparisons are disclosed.

12-02-2026

Thermo Fisher Scientific Inc. filed an 8-K on February 12, 2026 (AccNo: 0001140361-26-005014), reporting under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details, transaction values, financial metrics, positive or negative impacts, or period-over-period comparisons are disclosed in the provided filing summary.

12-02-2026

VenHub Global, Inc. filed a Form 8-K on February 12, 2026 (AccNo: 0001213900-26-015576), reporting under Item 1.01 entry into a material definitive agreement, Item 3.02 unregistered sales of equity securities, Item 8.01 other events, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific transaction values, financial metrics, or performance comparisons disclosed. No positive or negative metrics are provided.

12-02-2026

Sphere 3D Corp. filed a Form 8-K on February 12, 2026, reporting under Item 3.03 material modifications to the rights of security holders and under Item 5.03 amendments to its articles of incorporation or bylaws or a change in fiscal year. The filing also includes Item 7.01 for Regulation FD disclosure and Item 9.01 for financial statements and exhibits. No quantitative financial metrics, transaction values, or specific details on the modifications, impacts, or exhibits were disclosed in the provided information.

12-02-2026

Catheter Precision, Inc. filed a multi-item 8-K on February 12, 2026, disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), amendments to articles of incorporation or bylaws (Item 5.03), and Regulation FD disclosure (Item 7.01). While the material agreement may signal strategic progress, the unregistered equity sales raise potential dilution concerns and the governance changes introduce uncertainty without specified details. No quantitative transaction values, share counts, financial impacts, or period-over-period comparisons are disclosed.

12-02-2026

Lunai Bioworks Inc. filed a Form 8-K on 2026-02-12 disclosing under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, which represents a material negative event signaling potential removal from U.S. exchange trading. Item 7.01 includes a Regulation FD Disclosure. No financial metrics, positive developments, or quantitative details are disclosed.

12-02-2026

FrontView REIT, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001193125-26-048763), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, financial impacts, or quantitative metrics are disclosed in the provided information. No positive or negative performance metrics, period-over-period comparisons, or guidance changes are mentioned.

12-02-2026

BioMarin Pharmaceutical Inc filed an 8-K on February 12, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing for material events, but specific details on the agreement, transaction size, parties, or financial impacts are NOT_DISCLOSED. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.

12-02-2026

SPS Commerce Inc filed a Form 8-K on February 12, 2026, disclosing entry into a material definitive agreement under Item 1.01, departure or election of directors/officers or compensatory arrangements under Item 5.02, Regulation FD disclosure under Item 7.01, and financial statements/exhibits under Item 9.01. This is a multi-item filing with no specific transaction details, financial metrics, or quantitative impacts provided in the summary. No positive or negative metrics were disclosed.

12-02-2026

Carnival PLC filed an 8-K on February 12, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 3.03 material modifications to rights of security holders, with exhibits provided under Item 9.01. No specific details, financial terms, quantitative metrics, positive or negative impacts, or period-over-period comparisons are disclosed in the filing summary. This is a multi-item mandatory filing with no further transaction or impact data available.

12-02-2026

Origin Materials, Inc. filed a multi-item Form 8-K on February 12, 2026, reporting costs associated with exit or disposal activities under Item 2.05 alongside Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. This indicates a material restructuring or disposal event with associated costs, which is typically negative for earnings, while Item 7.01 may provide additional voluntary context. No specific dollar values, impacts, metrics, or period-over-period comparisons are disclosed.

12-02-2026

Cineverse Corp. filed a Form 8-K on 2026-02-12 reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 2.02 Results of Operations and Financial Condition, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific transaction details, financial metrics, or period-over-period comparisons disclosed in the provided information. No positive or negative metrics are available.

12-02-2026

Vail Resorts Inc filed an 8-K on February 12, 2026 (AccNo: 0000812011-26-000010), reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of the Registrant), with Item 9.01 providing Financial Statements and Exhibits. No specific details on the nature of the agreement, transaction value, financial terms, or impacts are disclosed. No quantitative metrics, period-over-period comparisons, or other performance data are mentioned.

12-02-2026

Xilio Therapeutics, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001193125-26-048942), disclosing under Item 1.01 entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the agreement, transaction value, financial impacts, or other quantitative metrics provided in the summary. No positive or negative metrics are disclosed.

12-02-2026

Sadot Group Inc. filed a Form 8-K on 2026-02-12 reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with financial statements and exhibits attached under Item 9.01. No quantitative details such as transaction values, share counts, financial impacts, or period-over-period comparisons are disclosed. This is a multi-item mandatory disclosure of material events.

12-02-2026

Corebridge Financial, Inc. filed a Form 8-K on 2026-02-12 disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 references financial statements and exhibits. No specific details, transaction values, financial metrics, positive or negative impacts, or comparisons are disclosed.

12-02-2026

Insight Molecular Diagnostics Inc. filed an 8-K on February 12, 2026, disclosing entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details, dollar values, financial impacts, or performance metrics (positive, negative, or flat) are disclosed in the provided filing summary.